Stage IA Melanoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma (NCT00003895) | National Cancer Institute (NCI) | 1999-04-01 |
Track Stage IA Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.